• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: CORDIS US. CORP PRECISE PRO RX OUS; STENT, CAROTID

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

CORDIS US. CORP PRECISE PRO RX OUS; STENT, CAROTID Back to Search Results
Catalog Number PC0940XCE
Device Problem Difficult or Delayed Positioning (1157)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 06/20/2023
Event Type  malfunction  
Event Description
As reported, the 9x40 precise pro rx stent could not be released and opened.The product evaluation showed that the stent was partially deployed approximately 1 cm.The case was completed with the use of a non-cordis stent.There was no reported injury to the patient.The device was prepped while in the tray.The touhy-borst valve was in the open position when received.The touhy-borst valve was opened when removed from the tray.The stent was still constrained within the outer member/sheath when removed from the tray.The stopcock was connected to the y-connector of the touhy-borst valve.There was no difficulty flushing the stopcock or while flushing the sds.The carotid artery had a stenosis.The lesion was at the carotid bifurcation.The lesion was measured to be 7.7mm in diameter.The lesion length was 33mm.The lesion had a 90% stenosis.The lesion was not calcified.The vessel was noted to have mild tortuosity.The diameter of the unconstrained stent size was 1-2 mm larger than the vessel diameter.The stent delivery system did not pass through any acute bends.There was no difficulty encountered while advancing/tracking the sds towards the lesion.There was no thrombus present proximal to, at, or distal to the lesion site.The lesion was pre-dilated.After dilatation, the lesion had a 60% stenosis.There was no difficulty or resistance noted while crossing the lesion with the device.The sds did not have to pass through a previously placed stent.The user maintained a fixed inner shaft position during deployment.The device will be returned for evaluation.
 
Manufacturer Narrative
As reported, the 9x40mm precise pro rx stent could not be released and opened.The case was completed with the use of a non-cordis stent.There was no reported injury to the patient.The device was prepped while in the tray.The touhy-borst valve was in the open position when received and was opened when removed from the tray.The stent was still constrained within the outer member/sheath when removed from the tray.The stopcock was connected to the y-connector of the touhy-borst valve.There was no difficulty flushing the stopcock or while flushing the stent delivery system (sds).The carotid artery had a 90% stenosis that was not calcified.The lesion was at the carotid bifurcation.The lesion was measured to be 7.7mm in diameter, and the length was 33mm.The vessel was noted to have mild tortuosity.The diameter of the unconstrained stent size was 1-2 mm larger than the vessel diameter.The stent delivery system did not pass through any acute bends.There was no difficulty encountered while advancing/tracking the sds towards the lesion.There was no thrombus present proximal to, at, or distal to the lesion site.The lesion was pre-dilated.After dilatation, the lesion had a 60% stenosis.There was no difficulty or resistance noted while crossing the lesion with the device.The sds did not have to pass through a previously placed stent.The user maintained a fixed inner shaft position during deployment.A non-sterile unit of ¿precise pro rx us carotid syst¿ was received for analysis.Per visual analysis, a thorough inspection was performed on the unit observing the following conditions: the device was not deployed; however, the stent was partially deployed approximately 1cm; and the hemostasis valve was returned disassembled.No other outstanding details were observed.Per dimensional analysis, the stroke length was measured, and results were found within specification.Functional analysis was performed to determine if the stent could be deployed as expected.The hemostasis valve of the stent delivery system was unlocked.The stent deployment functionality test was initiated by retracting the outer sheath while holding the inner shaft in a fixed position.However, the push rod did not travel toward the distal tip as expected, and it was not possible to deploy the stent.The unit was further evaluated, observing that the deployment mechanism was not working as expected as the inner shaft seems to be stuck inside the inner lumen.The product engineering team (pet) members performed several cross-section cuts to find out the condition of the inner shaft.Several sections were evaluated with a vision system by the pet, observing that the polyamide (black material) was strongly affixed to the inner shaft.A product history record (phr) review of lot 18121321 revealed no anomalies or non-conformances during the manufacturing and inspection processes that can be associated with the reported event.The reported event of ¿stent delivery system (sds)-deployment difficulty-unable¿ was confirmed through analysis of the returned device due to the inability to deploy the stent during functional analysis.Additionally, the returned unit presented a condition of ¿stent delivery system (sds)-deployment difficulty-partial deployment¿ as the stent was partially deployed 1cm.The cause of the deployment difficulty experienced by the customer was due to the polyamide adhering to the inner lumen of the device.According to the instructions for use (ifu), which is not intended as a mitigation, ¿extract the stent delivery system from the tray.Examine the device for any damage.Evaluate the distal end of the catheter to ensure that the stent is contained within the outer sheath.Do not use if the stent is partially deployed.¿ based on the product analysis, the issue appears to be related to the manufacturing process of the unit; therefore, this event was referenced under an existing risk assessment and investigation.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
PRECISE PRO RX OUS
Type of Device
STENT, CAROTID
Manufacturer (Section D)
CORDIS US. CORP
14201 nw 60 avenue
miami lakes FL 33014
Manufacturer (Section G)
CORDIS US CORP.
14201 nw 60 avenue
miami lakes FL 33014
Manufacturer Contact
karla castro
santiago troncoso 808
juarez, chihuahua 32574
MX   32574
7863138372
MDR Report Key18534052
MDR Text Key333115888
Report Number9616099-2024-00022
Device Sequence Number1
Product Code NIM
UDI-Device Identifier20705032062456
UDI-Public(01)20705032062456(17)240531(10)18121321
Combination Product (y/n)N
Reporter Country CodeCH
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Health Professional,Company Representative
Reporter Occupation Other Health Care Professional
Type of Report Initial
Report Date 01/18/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received01/18/2024
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Catalogue NumberPC0940XCE
Device Lot Number18121321
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer08/09/2023
Is the Reporter a Health Professional? Yes
Was the Report Sent to FDA? No
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured06/22/2022
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Treatment
NAV 6 WALLSTENT; UMBRELLA; UNKNOWN BALLOON
Patient Age85 YR
Patient SexMale
Patient Weight78 KG
-
-